JP2008545715A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008545715A5 JP2008545715A5 JP2008513812A JP2008513812A JP2008545715A5 JP 2008545715 A5 JP2008545715 A5 JP 2008545715A5 JP 2008513812 A JP2008513812 A JP 2008513812A JP 2008513812 A JP2008513812 A JP 2008513812A JP 2008545715 A5 JP2008545715 A5 JP 2008545715A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- betacellulin
- effective amount
- therapeutically effective
- situation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000056058 Betacellulin Human genes 0.000 claims 6
- 101800001382 Betacellulin Proteins 0.000 claims 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 4
- 230000001154 acute effect Effects 0.000 claims 3
- 108090001061 Insulin Proteins 0.000 claims 2
- 102000004877 Insulin Human genes 0.000 claims 2
- 201000001421 hyperglycemia Diseases 0.000 claims 2
- 229940125396 insulin Drugs 0.000 claims 2
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 1
- 102100025101 GATA-type zinc finger protein 1 Human genes 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 claims 1
- 108091016366 Histone-lysine N-methyltransferase EHMT1 Proteins 0.000 claims 1
- 108010057186 Insulin Glargine Proteins 0.000 claims 1
- 108010065920 Insulin Lispro Proteins 0.000 claims 1
- COCFEDIXXNGUNL-RFKWWTKHSA-N Insulin glargine Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(=O)NCC(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 COCFEDIXXNGUNL-RFKWWTKHSA-N 0.000 claims 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- WNRQPCUGRUFHED-DETKDSODSA-N humalog Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(O)=O)C1=CC=C(O)C=C1.C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 WNRQPCUGRUFHED-DETKDSODSA-N 0.000 claims 1
- 229960002869 insulin glargine Drugs 0.000 claims 1
- 229960002068 insulin lispro Drugs 0.000 claims 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 claims 1
- 229960003105 metformin Drugs 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- 201000004193 respiratory failure Diseases 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68570205P | 2005-05-27 | 2005-05-27 | |
| US70206505P | 2005-07-22 | 2005-07-22 | |
| US70196405P | 2005-07-22 | 2005-07-22 | |
| US70149005P | 2005-07-22 | 2005-07-22 | |
| US73379105P | 2005-11-07 | 2005-11-07 | |
| US73686605P | 2005-11-16 | 2005-11-16 | |
| US77816906P | 2006-02-27 | 2006-02-27 | |
| US80044306P | 2006-05-16 | 2006-05-16 | |
| PCT/US2006/020797 WO2006128125A2 (en) | 2005-05-27 | 2006-05-30 | Methods of and compositions for stimulation of glucose uptake into muscle cells and treatment of diseases |
| US11/442,244 US20070054851A1 (en) | 2005-05-27 | 2006-05-30 | Methods of and compositions for stimulation of glucose uptake into muscle cells and treatment of diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008545715A JP2008545715A (ja) | 2008-12-18 |
| JP2008545715A5 true JP2008545715A5 (enExample) | 2009-09-10 |
Family
ID=37452973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008513812A Pending JP2008545715A (ja) | 2005-05-27 | 2006-05-30 | 筋細胞へのグルコース取り込みを刺激する方法および組成物ならびに疾患を治療する方法および組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20070054851A1 (enExample) |
| EP (1) | EP1890722A2 (enExample) |
| JP (1) | JP2008545715A (enExample) |
| AU (1) | AU2006249327A1 (enExample) |
| CA (1) | CA2609728A1 (enExample) |
| WO (1) | WO2006128125A2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2009128237A (ru) * | 2006-12-22 | 2011-01-27 | Новеликс Терапьютикс Гмбх (At) | Лечение диабета, по меньшей мере, одним антителом, специфичным к рецептору эпидермального фактора роста, или его производным |
| DK2173407T3 (da) * | 2007-07-02 | 2020-04-27 | Hoffmann La Roche | Anordning til indgivelse af lægemiddel |
| US20090156488A1 (en) * | 2007-09-12 | 2009-06-18 | Zensun (Shanghai) Science & Technology Limited | Use of neuregulin for organ preservation |
| US20090147006A1 (en) * | 2007-12-07 | 2009-06-11 | Roche Diagnostics Operations, Inc. | Method and system for event based data comparison |
| CN102139095A (zh) | 2010-01-29 | 2011-08-03 | 上海泽生科技开发有限公司 | 神经调节蛋白用于预防、治疗或延迟心脏缺血再灌注损伤的方法和组合物 |
| JP6200806B2 (ja) * | 2010-05-21 | 2017-09-20 | メリマック ファーマシューティカルズ インコーポレーティッド | 二重特異的融合タンパク質 |
| CN103118698A (zh) * | 2010-05-28 | 2013-05-22 | 意识-Nrg公司 | 神经调节素同种型,神经调节素多肽和其使用 |
| US20130217778A1 (en) * | 2010-07-21 | 2013-08-22 | Herman H. Vandenburgh | Methods and compositions for the improvement of skeletal muscle function in a mammal |
| CN102145164B (zh) * | 2010-12-16 | 2013-02-27 | 深圳市健元医药科技有限公司 | 一种更加稳定的iapp类似物注射剂 |
| UA113626C2 (xx) | 2011-06-02 | 2017-02-27 | Композиція для лікування діабету, що містить кон'югат інсуліну тривалої дії та кон'югат інсулінотропного пептиду тривалої дії | |
| EP3527990A1 (en) * | 2011-07-28 | 2019-08-21 | metanomics GmbH | Use of sm_sphingomyelin (d18:1, c23:1) as a marker for heart failure |
| US10040840B2 (en) | 2015-10-02 | 2018-08-07 | Silver Creek Pharmaceuticals, Inc. | Bi-specific annexin A5/IGF-1 proteins and methods of use thereof to promote regeneration and survival of tissue |
| US10758560B2 (en) * | 2015-12-22 | 2020-09-01 | Societe Des Produits Nestle S.A. | Methods for treating sarcopenia and frailty |
| KR101908056B1 (ko) | 2017-05-25 | 2018-12-18 | 가천대학교 산학협력단 | 근아세포의 전기적 임피던스 모니터링 시스템 및 방법 |
| EP4126000A1 (en) * | 2020-03-31 | 2023-02-08 | Universität Heidelberg | Agents for use in the therapeutic or prophylactic treatment of retinal pigment epithelium associated diseases |
| WO2024253228A1 (ko) * | 2023-06-09 | 2024-12-12 | 주식회사 메타파인즈 | 악액질 및 근손실의 예방 또는 치료용 조성물 |
| EP4582080A1 (en) | 2024-01-02 | 2025-07-09 | G.ST Antivirals GmbH | Dispenser for mucosal administration comprising 2-deoxy-glucose or analogues thereof |
| WO2025170936A1 (en) * | 2024-02-05 | 2025-08-14 | The Board Of Trustees Of The Leland Stanford Junior University | Materials and methods for treating cardiac dysfunction |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE145939T1 (de) * | 1992-02-10 | 1996-12-15 | Takeda Chemical Industries Ltd | Mitogen für die glatte muskulatur und dessen kodierende dns |
| JP3945846B2 (ja) * | 1995-11-09 | 2007-07-18 | 武田薬品工業株式会社 | 膵臓機能改善剤 |
| ATE231727T1 (de) * | 1995-11-09 | 2003-02-15 | Takeda Chemical Industries Ltd | Zusammensetzung für verbesserung der pankreasfunktion |
| WO2000034478A1 (fr) * | 1998-12-09 | 2000-06-15 | Takeda Chemical Industries, Ltd. | Modification de betacelluline |
| ES2307505T3 (es) * | 1999-04-06 | 2008-12-01 | Genentech, Inc. | Utilizacion de ligandos receptores de erbb en el tratamiento de la diabetes. |
| DE60035192T2 (de) * | 1999-04-26 | 2008-02-14 | Applied Protein Sciences, LLC, Mountain View | Tgf-alpha polypeptide, funktionelle fragmente und verfahren zu ihrer anwendung |
| US6815418B2 (en) * | 1999-08-19 | 2004-11-09 | Kaleidos Pharma, Inc. | TGF-α polypeptides, functional fragments and methods of use therefor |
| AUPQ496900A0 (en) * | 2000-01-06 | 2000-02-03 | Gropep Pty Ltd | Growth factor splice variant |
| EP2357004B1 (en) * | 2000-05-23 | 2016-10-12 | CeNeS Pharmaceuticals, Inc. | NRG-2 nucleic acid molecules, polypeptides and diagnostic and therapeutical methods |
| US20040132679A1 (en) * | 2002-09-03 | 2004-07-08 | Baylor College Of Medicine | Induction of pancreatic islet formation |
| US20060035844A1 (en) * | 2002-12-04 | 2006-02-16 | Fumiaki Ito | Preventive or remedy for diseases caused by hyperglycemia |
-
2006
- 2006-05-30 EP EP06760525A patent/EP1890722A2/en not_active Withdrawn
- 2006-05-30 US US11/442,244 patent/US20070054851A1/en not_active Abandoned
- 2006-05-30 AU AU2006249327A patent/AU2006249327A1/en not_active Abandoned
- 2006-05-30 CA CA002609728A patent/CA2609728A1/en not_active Abandoned
- 2006-05-30 JP JP2008513812A patent/JP2008545715A/ja active Pending
- 2006-05-30 WO PCT/US2006/020797 patent/WO2006128125A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008545715A5 (enExample) | ||
| JP2020033360A5 (enExample) | ||
| HRP20131120T1 (hr) | Farmaceutski pripravak koji sadrži (1s)-1,5-anhidro-1-[5-(4-etoksibenzil)-2-metoksi-4-metilfenil]-1-tio-d-glucitol i metformin, te njegova uporaba za lijeäśenje dijabetesa | |
| JP2010530001A5 (enExample) | ||
| JP2011500850A5 (enExample) | ||
| JP2013541576A5 (enExample) | ||
| BRPI0818687A2 (pt) | composto espiro, o sal deste farmaceuticamente aceitavél ou o solvato deste, composição farmacêutica, medicamento agonista de gpr40, agente promotor da secreção de insulina ou um agente hipoglicêmico, uso do composto espíro, o sal deste farmaceuticamente aceitavél ou o solvato deste, e, métodos para a ativação de gpr40, para promover secreção de insulina ou diminuir o nível de glicose sanguínea, e para tratar ou prevenir uma doença. | |
| NO20084919L (no) | Oksadiazolidindionforbindelse | |
| MX2012006744A (es) | Tiazolidinadionas reguladores de receptores activados por proliferador de peroxisoma (ppar) y combinaciones para el tratamiento de diabetes mellitus y otras enfermedades metabolicas. | |
| AR081254A1 (es) | Composicion farmaceutica que comprende ave0010 e insulina glargina | |
| JP2011241213A5 (enExample) | ||
| NZ594044A (en) | Antidiabetic medications comprising a dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetics | |
| JP2011529083A5 (enExample) | ||
| JP2011512856A5 (enExample) | ||
| JP2012236849A5 (enExample) | ||
| MX2011007371A (es) | Metodo para tratar la hiperglucemia con la molecula. | |
| MX336657B (es) | Prevencion de hipoglucemia en pacientes con diabetes sacarina de tipo 2. | |
| ES2922551T3 (es) | Tratamiento de pacientes con diabetes mellitus tipo 2 | |
| JP2013541583A5 (enExample) | ||
| JP2008545703A5 (enExample) | ||
| JP2020536121A5 (enExample) | ||
| JP2007119497A5 (enExample) | ||
| JP2009500045A5 (enExample) | ||
| WO2009133470A3 (en) | Use of dronedarone alone or in combination for preparing a medicament for the treatment of patients with arrhythmia and having an increase of creatinine level | |
| RU2020140694A (ru) | Способ лечения гипергликемии |